Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT01623856
Eligibility Criteria:
Inclusion Criteria:
* Slides and/or other available specimens from patients diagnosed with lymphoblastic lymphoma (LL) or Burkitt lymphoma ( BL) enrolled on the Children Oncology Group (COG) protocols 5961, A5971, and ANHL01P1 collected at the time of diagnosis and currently housed at the Biopathology Center at Nationwide Children's Hospital
* Samples from non-Hispanic white patients
* DNA samples from 384 healthy, anonymous, non-Hispanic white blood donors used as controls
* See Disease Characteristics
* Not specified
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
20 Years
Study:
NCT01623856
Study Brief:
Protocol Section:
NCT01623856